Specific Susceptibility to COVID-19 in Adults with Down Syndrome

dc.contributor.authorIllouz, Tomer
dc.contributor.authorBiragyn, Arya
dc.contributor.authorFrenkel‑Morgenstern, Milana
dc.contributor.authorWeissberg, Orly
dc.contributor.authorGorohovski, Alessandro
dc.contributor.authorMerzon, Eugene
dc.contributor.authorGreen, Ilan
dc.contributor.authorIulita, Florencia
dc.contributor.authorFlores-Aguilar, Lisi
dc.contributor.authordel Mar Dierssen Sotos, Maria
dc.contributor.authorDe Toma, Ilario
dc.contributor.authorLifshitz, Herziba
dc.contributor.authorAntonarakis, Stylianos E.
dc.contributor.authorYu, Eugene
dc.contributor.authorHerault, Yann
dc.contributor.authorPotier, Marie-Claude
dc.contributor.authorBotté, Alexandra
dc.contributor.authorRoper, Randall
dc.contributor.authorSredni, Benjamin
dc.contributor.authorSarid, Ronit
dc.contributor.authorLondon, Jacqueline
dc.contributor.authorMobley, William
dc.contributor.authorStrydom, Andre
dc.contributor.authorOkun, Eitan
dc.contributor.departmentBiology, School of Scienceen_US
dc.date.accessioned2021-04-20T19:59:21Z
dc.date.available2021-04-20T19:59:21Z
dc.date.issued2021
dc.description.abstractThe current SARS-CoV-2 outbreak, which causes COVID-19, is particularly devastating for individuals with chronic medical conditions, in particular those with Down Syndrome (DS) who often exhibit a higher prevalence of respiratory tract infections, immune dysregulation and potential complications. The incidence of Alzheimer’s disease (AD) is much higher in DS than in the general population, possibly increasing further the risk of COVID-19 infection and its complications. Here we provide a biological overview with regard to specific susceptibility of individuals with DS to SARS-CoV-2 infection as well as data from a recent survey on the prevalence of COVID-19 among them. We see an urgent need to protect people with DS, especially those with AD, from COVID-19 and future pandemics and focus on developing protective measures, which also include interventions by health systems worldwide for reducing the negative social effects of long-term isolation and increased periods of hospitalization.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationIllouz, T., Biragyn, A., Frenkel-Morgenstern, M., Weissberg, O., Gorohovski, A., Merzon, E., ... & Okun, E. (2021). Specific Susceptibility to COVID-19 in Adults with Down Syndrome. Neuromolecular Medicine, 1-11. https://doi.org/10.1007/s12017-021-08651-5en_US
dc.identifier.urihttps://hdl.handle.net/1805/25697
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.isversionof10.1007/s12017-021-08651-5en_US
dc.relation.journalNeuromolecular Medicineen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0*
dc.sourcePublisheren_US
dc.subjectCOVID-19en_US
dc.subjectdown syndromeen_US
dc.subjectimmune dysregulationen_US
dc.titleSpecific Susceptibility to COVID-19 in Adults with Down Syndromeen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Illouz2021Specific.pdf
Size:
855.12 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: